Chronic viral hepatitis—‘B’ aware and ‘C’ the new possibilities

Highlights in this issue

“…Two papers in this issue focus on chronic viral hepatitis in two very different settings. Norden et al 1 report epidemiological data from a high‐income Scandinavian country with a low prevalence of hepatitis B and hepatitis C. El‐Shabrawi et al 2 focus on Egypt, a low‐middle income country with a high prevalence of chronic hepatitis C. Psaros Einberg and Fischler comment on the findings 3 …”

Treatment of Chronic Hepatitis C Virus Infection in Children

“…No data from controlled trials are available on the use of DAAs in children with coinfections (HBV, HIV), comorbidities (renal impairment, nonhepatic solid organ transplant recipients, children before and after liver transplantation, active drug users, patients with hemoglobinopathies and coagulation disorders) and nonsustained virological responders to DAAs. Isolated and highly promising experiences with young children undergoing liver transplantation or with cirrhosis are available (67,68). There is an ongoing debate as to whether adults with decompensated cirrhosis without hepatocellular carcinoma awaiting liver transplantation should be treated for their HCV infection before or after liver transplantation.…”